16-84191289-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The ENST00000315906.10(ADAD2):āc.59C>Gā(p.Ala20Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000135 in 1,603,918 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000066 ( 0 hom., cov: 35)
Exomes š: 0.00014 ( 0 hom. )
Consequence
ADAD2
ENST00000315906.10 missense
ENST00000315906.10 missense
Scores
2
6
11
Clinical Significance
Conservation
PhyloP100: 3.73
Genes affected
ADAD2 (HGNC:30714): (adenosine deaminase domain containing 2) Predicted to enable double-stranded RNA adenosine deaminase activity; double-stranded RNA binding activity; and tRNA-specific adenosine deaminase activity. Predicted to be involved in RNA processing and adenosine to inosine editing. Predicted to be active in cytoplasm and nucleolus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3236838).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAD2 | NM_001145400.2 | c.59C>G | p.Ala20Gly | missense_variant | 1/10 | ENST00000315906.10 | NP_001138872.1 | |
ADAD2 | NM_139174.4 | c.59C>G | p.Ala20Gly | missense_variant | 1/11 | NP_631913.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAD2 | ENST00000315906.10 | c.59C>G | p.Ala20Gly | missense_variant | 1/10 | 1 | NM_001145400.2 | ENSP00000325153 | P1 | |
ADAD2 | ENST00000268624.7 | c.59C>G | p.Ala20Gly | missense_variant | 1/11 | 2 | ENSP00000268624 | |||
ADAD2 | ENST00000567413.1 | n.99C>G | non_coding_transcript_exon_variant | 1/2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152248Hom.: 0 Cov.: 35
GnomAD3 genomes
AF:
AC:
10
AN:
152248
Hom.:
Cov.:
35
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000997 AC: 23AN: 230602Hom.: 0 AF XY: 0.000102 AC XY: 13AN XY: 127754
GnomAD3 exomes
AF:
AC:
23
AN:
230602
Hom.:
AF XY:
AC XY:
13
AN XY:
127754
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000142 AC: 206AN: 1451670Hom.: 0 Cov.: 89 AF XY: 0.000151 AC XY: 109AN XY: 721160
GnomAD4 exome
AF:
AC:
206
AN:
1451670
Hom.:
Cov.:
89
AF XY:
AC XY:
109
AN XY:
721160
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152248Hom.: 0 Cov.: 35 AF XY: 0.0000403 AC XY: 3AN XY: 74390
GnomAD4 genome
AF:
AC:
10
AN:
152248
Hom.:
Cov.:
35
AF XY:
AC XY:
3
AN XY:
74390
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
11
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2023 | The c.59C>G (p.A20G) alteration is located in exon 1 (coding exon 1) of the ADAD2 gene. This alteration results from a C to G substitution at nucleotide position 59, causing the alanine (A) at amino acid position 20 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L
MutationTaster
Benign
D;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Pathogenic
D;D
Sift4G
Pathogenic
D;D
Polyphen
D;D
Vest4
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at